SEC Filings

SEC Filings

Filing date	Description	Form	View
Nov 04, 2015	Initial filing by director officer or owner of more than ten percent.	3	View HTML 0001209191-15-078468.pdf 0001209191-15-078468.rtf
Nov 04, 2015	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-15-078471.pdf 0001209191-15-078471.rtf
Nov 02, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-361310.pdf 0001193125-15-361310.rtf 0001193125-15-361310.xls
Oct 13, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-342829.pdf 0001193125-15-342829.rtf 0001193125-15-342829.xls
Sep 15, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-320583.pdf 0001193125-15-320583.rtf 0001193125-15-320583.xls
Sep 01, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-308467.pdf 0001193125-15-308467.rtf 0001193125-15-308467.xls
Aug 26, 2015	Form of prospectus reflecting facts events constituting substantive change from last form	424B3	View HTML 0001193125-15-301990.pdf 0001193125-15-301990.rtf 0001193125-15-301990.xls
Aug 26, 2015	Form of prospectus reflecting facts events constituting substantive change from last form	424B3	View HTML 0001193125-15-301986.pdf 0001193125-15-301986.rtf 0001193125-15-301986.xls
Aug 25, 2015	Report of unscheduled material events or corporate event	8-K	View HTML 0001193125-15-300831.pdf 0001193125-15-300831.rtf 0001193125-15-300831.xls
Aug 25, 2015	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-15-067800.pdf 0001209191-15-067800.rtf

Data provided by Kaleidoscope.

For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE